Why This Overlooked Seattle Drugmaker Could be the Best Biotech Buy Right Now Post author:Sam Post published:November 28, 2017 Post category:BioPharma Omeros is getting a lot of love from investors and analysts these days. Source: BioSpace You Might Also Like Wolters Kluwer nv Provides Multilingual, Workflow-integrated Patient Education For MEDITECH EHR Users April 10, 2017 GeneNews Announces Contract With Large Multi-Specialty Physician Group For Use Of Early Cancer Diagnostic Tests March 15, 2017 5 Massachusetts Biotechs That Tanked More Than 60% in 2017 January 1, 2018
Wolters Kluwer nv Provides Multilingual, Workflow-integrated Patient Education For MEDITECH EHR Users April 10, 2017
GeneNews Announces Contract With Large Multi-Specialty Physician Group For Use Of Early Cancer Diagnostic Tests March 15, 2017
